No Data
No Data
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association With Small Cap Discoveries on Thursday, September 26, 2024
Crescita Therapeutics Down 4.5% As Reports Wider Q2 Net Loss On Lower Revenues
Stocks in Play: Crescita Therapeutics Inc.
Crescita Therapeutics Introduces "World's Smallest Intradermal Delivery Device"
Crescita Therapeutics Announces the Results of Its Annual General and Special Meeting of Shareholders